Skip to main content

Table 2 Comparison of the median value of serum ESM-1 concentration

From: Evaluation of endothelial cell-specific molecule-1 as a biomarker of glycocalyx damage in canine myxomatous mitral valve disease

ESM-1 (pg/mL)

P-value

Control

MMVD

0.303a

 175.2 (111, 202.7)

193.6 (133.2, 301.8)

MMVD w/ co-morbid

MMVD w/o co-morbid

0.449b

 178.0 (117.9, 273.3)

226.6 (139.9, 317.4)

Death

Alive

0.006c

 345.6 (231.8, 650.6)

191. 6 (103.2, 296.6)

B1

B2

C

D

0.886d

 211.3 (152.4, 249.1)

174.1 (118.9, 287.9)

221.5 (132.8, 331.0)

220.5 (115.1, 361.4)

  1. Data are presented as median (and IQR). B1, B2, C, D represents the stage of MMVD ACVIM stage
  2. Abbreviations: ESM-1 Endothelial cell-specific molecule-1, MMVD Myxomatous mitral valve disease, IQR Interquartile range
  3. aComparison between control and MMVD group
  4. bComparison between MMVD w/ co-morbid and w/o co-morbid group
  5. cComparison between death and alive group
  6. dComparison between MMVD stages